Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein by Cruz, Catherine C. et al.
Modulation of type I IFN induction by a virulence determinant
within the Alphavirus nsP1 protein
Catherine C. Cruzb,c,*, Mehul S. Suthard,*, Stephanie A. Montgomeryb,c, Reed Shabmanb,c,
Jason Simmonsb,c, Robert E. Johnstonb,c, Thomas E. Morrisona,b,c, and Mark T.
Heisea,b,c,**
a Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
27599
b Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina 27599
c Carolina Vaccine Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina 27599
d Department of Immunology, University of Washington, Seattle, Washington 98195-76504
Abstract
Alphaviruses are mosquito-borne viruses that cause serious human and animal diseases. Previous
studies demonstrated that a determinant within the nsP1/nsP2 cleavage domain of the virulent Sindbis
AR86 virus played a key role in regulating adult mouse virulence without adversely affecting viral
replication. Additional characterization of this determinant demonstrated that a virus with the
attenuating mutation induced more type I IFN production both in vivo and in vitro. Interestingly, this
phenotype was not specific to the Sindbis AR86 virus, as a similar mutation in a distantly related
alphavirus, Ross River Virus (RRV), also led to enhanced IFN induction. This effect was independent
of virus-induced host shutoff, since IRF-3 phosphorylation, which occurs independently of de
novo host transcription/translation, was induced more robustly in cells infected with the mutant
viruses. Altogether, these results demonstrate that critical determinants within the nsP1/nsP2
cleavage domain play an important role in regulating alphavirus induced IFN responses.
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Introduction
Alphaviruses are mosquito-borne viruses capable of infecting humans and causing various
diseases ranging from acute encephalitis to long-term virus-induced arthritis. The Sindbis-
group viruses are among the most studied and well characterized of the alphaviruses, having
been used to identify viral and host factors that contribute to virus-induced disease in mice
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(Morrison, Simmons, and Heise, 2008; Ryman et al., 2002; Suthar et al., 2005). The majority
of the Sindbis virus strains are a virulent in adult mice, however, there are a few exceptions,
including the neurovirulent neuroadapted Sindbis virus (NSV) (Tucker et al., 1993) and AR86
strains (Heise, Simpson, and Johnston, 2000; Simpson et al., 1996). Genetic studies have
mapped virulence determinants of these neurovirulent viruses to both the structural and
nonstructural proteins. Detailed genetic mapping studies using chimeric viruses that encode
regions of the adult mouse virulent AR86 and the closely related a virulent Girdwood S.A
identified four major neurovirulence determinants in the AR86 genome including, a Threonine
at nsP1 position 538, an 18-amino acid deletion at nsP3 386, a Cysteine at nsP3 position 537,
and a Serine at E2 position 243 (Suthar et al., 2005). While all four determinants were found
to be essential for adult mouse virulence, the determinant within nsP1 was found to be critical;
as a single coding change of this determinant from a Thr to Ile severely attenuated the virus,
while introduction of a Thr at this position into non-virulent viruses partially rescued virulence
(Heise, Simpson, and Johnston, 2000). Currently, the exact mechanism by which this
determinant affects viral virulence is not understood.
The alphavirus nonstructural proteins form the viral replication complex that mediates
cytoplasmic viral RNA synthesis within infected cells. Nonstructural polyprotein processing
is intimately linked to viral RNA synthesis (Lemm and Rice, 1993; Shirako and Strauss,
1994). Upon viral entry, the virion-associated RNA is immediately translated to form the
replication complex consisting of the nonstructural precursor, nsP123, and nsP4, which
together mediate negative strand RNA synthesis (Strauss and Strauss, 1994). Later in the course
of infection, the polyprotein precursor nsP123 is further processed by nsP2 to produce mature
nsP1, nsP2, and nsP3. The mature nonstructural proteins, together with nsP4, form the
replication complex to synthesize full length genomic RNA. The mature nsPs also bind to an
internal subgenomic promoter to synthesize smaller subgenomic RNAs that encode the viral
structural proteins. Previous studies using mutants that lack the ability to efficiently process
the nonstructural polyprotein precursor nsP123 showed dysregulation of viral RNA synthesis
(Lemm and Rice, 1993). Interestingly, the wild type AR86 Thr to Ile change at nsP1 position
538, is located in the P3 position of the conserved nsP1/2 cleavage recognition domain (Shirako
and Strauss, 1994). The presence of an attenuating Ile at this position results in increased
kinetics of nonstructural polyprotein processing as well as earlier induction of 26S subgenomic
RNA synthesis. Furthermore, this mutation did not affect full length negative or positive strand
RNA synthesis, though it did result in increased virus production (Heise et al., 2003). Whether
differential nonstructural protein processing or the increased 26S RNA is important for the
attenuated phenotype of this virus in vivo has yet to be determined.
In addition to mediating viral replication, the nonstructural proteins interact with host factors
to alter environmental conditions that favor viral replication (Garmashova et al., 2006;
Montgomery et al., 2006). The nonstructural proteins of Old World alphaviruses, such as
Sindbis and Semliki Forest virus, have been shown to mediate shutoff of host transcription and
translation (Garmashova et al., 2007). While the exact mechanism of virus-mediated host
shutoff is not completely understood, it has been proposed that mature nsP2 is required
(Gorchakov, Frolova, and Frolov, 2005; Gorchakov et al., 2008). Alphaviruses are thought to
down regulate host mRNA and protein synthesis in order to limit competition for the cellular
machinery to maximize viral replication while simultaneously limiting induction of type I IFN
and related IFN stimulated genes (ISGs).
Sindbis viruses are highly sensitive to the effects of type I IFN (Frolova et al., 2002). Type I
IFN receptor deficient mice exhibited enhanced susceptibility to Sindbis virus marked by
increased virulence, broadened tissue tropism, and uncontrolled virus replication (Ryman et
al., 2000), demonstrating that type I IFN plays an important role in controlling Sindbis virus
infection. Therefore, it is likely that Sindbis virus utilizes several mechanisms to limit and/or
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suppress type I IFN induction. One likely mechanism involves generalized suppression of host
macromolecular synthesis. In support of this, Sindbis virus mutants that are defective for host
shutoff are more potent inducers of the type I IFN response (Gorchakov, Frolova, and Frolov,
2005; Gorchakov et al., 2008). However, host shutoff independent mechanisms likely exist, as
a mutation in the nsP2 protein of Semliki Forest Virus, a related alphavirus, affects type I IFN
induction independently of generalized host shutoff (Breakwell et al., 2007).
In this study, we demonstrate an important role for a determinant at the P3 cleavage position
between nsP1 and nsP2 in regulating type I IFN induction. Mutation of this position in two
distantly related alphaviruses, the AR86 strain of Sindbis and Ross River Virus, resulted in
enhanced type I IFN induction and IRF-3 activation in comparison to the wild type viruses.
Furthermore, the P3 mutation had little effect on kinetics of virus mediated host transcription
and translation shutoff. Taken together, these results suggest that the P3 determinant, which
regulates AR86 virulence, plays a major role in regulating type I IFN induction that is
independent of virus mediated host shutoff.
Results
An attenuating Isoleucine mutation at nsP1 position 538 (T538I) in the Sindbis virus AR86
backbone leads to increased type I IFN induction in vivo and in vitro
A virulence determinant located within the nsP1/nsP2 cleavage domain (nsP1 538) of the
Sindbis virus, AR86, regulates viral nonstructural polyprotein processing and subgenomic
RNA synthesis (Heise et al., 2003). Given that the presence of the attenuating Ile mutation led
to earlier induction of viral 26S RNA synthesis, which could alter type I IFN induction, we
assessed whether the attenuated mutant virus exhibited any differences in type I IFN induction
from that of the wild type virus both in vivo and in vitro. To evaluate whether the viruses
exhibited differential IFN induction in vivo, six-week old CD-1 mice were mock infected or
infected with the wild type AR86 (previously referenced as s300 (Suthar et al., 2005)) or mutant
T538I (nsP1 538 Ile previously referenced as s340) viruses by the intracranial route (i.c.) and
bled between 9 and 18 hours post infection. Serum type I interferon responses were measured
using an interferon bioassay on L929 cells. As shown in figure 1A, serum from mice infected
with the mutant T538I virus exhibited robust type I interferon levels compared to mice infected
with the wild type AR86 virus at both 12 and 18 hours post infection as detectable by bioassay.
Similar results were observed in C57BL/6 mice (data not shown). Importantly, wild type AR86
did not induce detectable type I interferon up to 48 hours post-infection (data not shown),
indicating that the wild type virus was not simply delayed in the induction of type I interferon.
To further assess whether the mutant virus was a more potent inducer of type I IFN, L929 cells
were infected with either the wild type AR86 virus or the T538I mutant and type I IFN levels
in the supernatant were evaluated. As shown in figure 1B, similar to the in vivo results, the
attenuated mutant was a more potent inducer of type I IFN than the wild type virus. These
results were not restricted to L929 cells, since the mutant virus was also a more potent IFN
inducer in human cell lines such as A549 cells (data not shown). Overall, these results suggest
that the determinant at nsP1 position 538 plays a major role in regulating type I IFN induction
by the virus.
Previous studies with Sindbis viruses have suggested that virus-mediated host cellular
macromolecular shutoff is linked to IFN induction. Some Sindbis virus mutants that are potent
IFN inducers are also defective in their ability to shutoff host RNA synthesis (Gorchakov,
Frolova, and Frolov, 2005), raising the possibility that the nsP1 mutation in AR86 affected
type I IFN induction through effects on host macromolecular synthesis. Therefore, we assessed
the kinetics of transcriptional and translational shutoff between the wild type and mutant AR86
viruses. These studies utilized L929 cells, since the T538I mutant exhibited enhanced type I
IFN induction in this cell type (figure 1B). Unfortunately, we were unable to achieve 100%
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infection at low MOIs. Therefore, the MOI was increased to 50 to increase the percent of
infected cells and to limit the confounding effect of nonproductively infected cells in the culture
continuing transcription/translation and complicating the analysis of virus-induced shutoff of
these processes. As shown in figure 2A, both the wild type and the mutant viruses exhibited
similar kinetics of host transcription shutoff at 5 hours post-infection as observed by the loss
of host mRNA, 28S rRNA, and 18S rRNA. By 8hpi, both viruses have efficiently turned off
host transcription. Interestingly, in Neuro2A cells, the wild type Sindbis AR86 virus exhibited
less efficient shutoff of host mRNA, 28S rRNA and 18S rRNA as compared to the mutant
T538I virus suggesting that the T538I mutant may actually shutoff transcription more
efficiently than the wild type virus (data not shown). Additionally, the wild type and mutant
Sindbis viruses were equally efficient at inhibiting host protein translation (figures 2B and 2C).
As early as 4 hours post-infection, both viruses exhibit greater than 25% shutoff of host protein
synthesis and by 8 hours post-infection greater than 75% of host protein synthesis shutoff was
observed (figure 2C). Most importantly, when comparing the β-actin band, the mutant T538I
virus displayed similar kinetics of host protein shutoff as compared to wild type AR86 virus
(figure 2B). Similar observations were also made in Neuro2A and BHK-21 cells (data not
shown). These results suggest that the Sindbis virus mutant induced enhanced type I IFN
production in the absence of a detectable defect in generalized host cell shutoff.
Mutation of the nsP1 determinant in Ross River Virus results in enhanced type I IFN induction
by the mutant virus
To determine if the effect of the amino acid within the nsP1/nsP2 cleavage domain on type I
IFN induction was specific to AR86, similar mutations were introduced in the distantly related
alphavirus, Ross River Virus (RRV) (figure 3A). RRV encodes an Alanine codon at the same
position within the nsP1/2 cleavage site and we examined whether substitution with an
Isoleucine (A532I) or Valine (A532V) would result in a viable virus with similar effects on
type I IFN induction as seen with the Sindbis T538I mutant (figure 1). Substitution of an
Isoleucine in RRV resulted in a significantly attenuated virus that grew poorly in BHK-21 cells
(data not shown). In contrast, substitution of an Alanine to Valine resulted in a viable virus
that grew to levels comparable to wild type RRV, though the Valine mutant displayed a smaller
plaque phenotype on BHK-21 cells (data not shown). Furthermore, the RRV A532V mutant
had a similar RNA specific infectivity and particle to PFU ratio to those observed with the wild
type virus (data not shown). In both single (figure 3B) and multistep (figure 3C) growth curves
in BHK-21 cells, the A532V mutant exhibited a significant and reproducible reduction in viral
yield at intermediate times (7–16hpi), although the endpoint yield was identical to wild type
RRV. Therefore, the A532V mutant is viable, though it may exhibit a slight replication defect
as compared to the wild type virus.
In order to assess the impact of the A532V mutation on type I IFN induction, L929 cells were
infected with either the wild type RRV or the RRV A532V mutant, and type I IFN induction
in the supernatant was measured by bioassay. As shown in figure 4A, the A532V mutant
exhibited enhanced IFN induction (~90 fold) in comparison to wild type RRV at 24 hours post-
infection. Similar results were found by qRT-PCR analysis for IFN-beta mRNA transcripts at
early times post-infection (figure 4B and 4C). Altogether, these data, along with the earlier
findings with the Sindbis AR86 viruses, highlight the importance of the determinant within
the nsP1/nsP2 cleavage site in modulating type I IFN responses by at least two alphaviruses.
The A532V mutation affects type I IFN induction
Recent work from our group and others has demonstrated that another alphavirus, Venezuelan
equine encephalitis virus (VEEV) can antagonize STAT1 activation following treatment with
type I IFN (Simmons et al., 2009; Yin et al., 2009). Although, to date we have found no evidence
that wild type RRV can antangonize STAT1 activation (Simmons and Heise, unpublished),
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we were interested in determining whether the A532V mutation affected the early induction
of type I IFN or the amplification phase of the type I IFN response, which is dependent upon
type I IFN signaling and STAT1 activation. Thus, we compared the wild type and mutant
A532V RRV viruses for their ability to induce type I IFN in primary MEFs derived from wild
type mice or mice deficient in the type I IFN αβ receptor (IFNR), which are therefore unable
to mount an amplified type I IFN response. As shown in figure 5A, similar to the results from
the L929 cells, the mutant virus was a more potent type I IFN inducer than wild type RRV in
wild type MEFs. In IFNR deficient MEFs, the overall type I IFN induction was reduced
compared to wild type cells, however the mutant virus still induced significantly more type I
IFN than the wild type virus (figure 5B). Therefore, though we cannot rule out an effect of the
A532V mutation on type I IFN signaling and subsequent amplification of the IFN response,
these results strongly suggest that the nsP1 mutation does have an effect on the inductive phase
of the type I IFN response.
The RRV A532V exhibits a mild defect in virus-induced shutoff of host RNA and protein
synthesis
The Sindbis T538I mutant exhibited little defect in virus-induced shutoff, therefore we
determined whether this was also the case with the RRV A532V mutant. RRV or A532V were
evaluated for their ability to shut off host protein and RNA synthesis in a manner similar to
that described above for AR86. L929 cells were infected with the RRV viruses at an MOI of
50 to enhance the percentage of infected cells in the culture. At this MOI, the percentage of
infected cells was greater than 80% for both viruses as demonstrated by an Immunofluorescent
Assay (IFA) (data not shown). Importantly, the RRV A532V mutant still induced an enhanced
IFN response compared to the wild type virus at this MOI (Figure 6D). Both wild type RRV
and the mutant A532V viruses inhibited cellular RNA transcription as early as 5 hours post-
infection as indicated by the decline in 18S rRNAs as compared to mock infected cells (figure
6A). By 8 hours post-infection, both viruses efficiently turned off 18S rRNA synthesis. Similar
results were also obtained in BHK cells though interestingly, in BHK cells, the A532V mutant
displayed a slight delay in transcriptional shutoff at early times post-infection compared to the
wild type RRV virus (data not shown). Therefore, though the A532V mutant is capable of
shutting off host RNA synthesis we cannot rule out the possibility that the A532V mutant virus
may be slightly delayed in its ability to turn off cellular RNA synthesis. Analysis of virus
induced inhibition of host protein synthesis (figure 6B) demonstrated that both viruses inhibit
cellular protein synthesis in L929 cells with similar kinetics as indicated by the loss of the β-
actin band (figure 6C). Similarly to the transcriptional shutoff data, in BHK cells, the A532V
mutant was slightly delayed in inhibiting protein translation in comparison to the wild type
virus (data not shown). Therefore, though the mutant RRV is ultimately able to shut off host
cell RNA and protein synthesis, based on these results, we cannot rule out the possibility that
a slight defect in shutoff might contribute to the enhanced type I IFN induction by the A532V
RRV mutant.
The A532V mutant virus is a strong inducer of IRF-3 phosphorylation than the wild type virus
The results with the Sindbis T538I mutant suggest that host shutoff defects do not contribute
to the enhanced type I IFN induction by the mutant virus. Furthermore, though we could not
detect a defect in the RRV A532V mutant’s ability to shutoff host transcription or translation
in L929 cells, the delayed kinetics of shutoff by the A532V mutant in BHK cells left open the
possibility of shutoff dependent effects for the RRV mutant. Therefore, to more clearly address
this issue, we assessed the RRV viruses for their ability to activate IRF-3, a step that is
independent of de novo host RNA and protein synthesis and therefore not susceptible to shutoff
mediated effects (Preston, Harman, and Nicholl, 2001). IRF-3 is an essential transcription
factor that is immediately activated by several pathogen-associated molecular pattern receptors
to induce early transcription of IFN-β and IFN-α genes. Activation is initiated upon IRF-3
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phosphorylation resulting in protein dimerization and nuclear translocation. Therefore, we
assessed whether the mutant RRV virus exhibited differential IRF-3 activation compared to
the wild type RRV in L929 cells, which exhibited high levels of type I IFN induction by the
RRV A532V mutant (figure 4A). L929 cells were transfected with poly IC as a positive control
(Hato et al., 2007), which resulted in robust IRF-3 phosphorylation as indicated by the shift in
the IRF-3 protein band in comparison to the mock treated cells (Figure 7A). Additionally,
phosphatase treatment of cell lysates confirmed that the upper band was indeed a
phosphorylated protein (data not shown). Analysis of the virally infected cells demonstrated
that the RRV A532V mutant virus induced IRF-3 phosphorylation at 10 hours post-infection;
however, the wild type RRV virus did not display IRF-3 phosphorylation until as late as 12
hours post-infection. Also, there was substantially more IRF-3 phosphorylation at 12 hours
post-infection in cells infected with the A532V mutant virus (figure 7B), consistent with our
previous data that the RRV A532V mutant induces more IFN than wild type RRV. Similar to
the results with RRV, the AR86 T538I mutant induced faster and more robust IRF-3 activation
than the wild type virus in HEC-1B cells, human endometrial carcinoma cells, that have been
well characterized in IRF-3 activation studies and do not respond to IFN treatment (Chen et
al., 1981; Talon et al., 2000)(data not shown). Altogether, these results suggest that both the
AR86 and RRV mutants affect IFN induction through a mechanism that is independent of
virus-induced host shutoff. However, given that the RRV A532V mutant did exhibit delayed
shutoff kinetics in BHK cells, we cannot rule out a synergistic role for shutoff dependent and
independent effects in enhancing type I IFN induction by the RRV A532V mutant.
Discussion
Type I interferon is an essential component of the host response to viral infection, because it
directly activates antiviral systems and modulates antiviral activities of other components of
the host innate and adaptive immune systems. However, a number of viruses have evolved
mechanisms to antagonize or evade type I IFN induction. These mechanisms range from
nonspecific effects, such as rapid shutoff of host cell macromolecular synthesis (Ahmed et al.,
2003; Gorchakov, Frolova, and Frolov, 2005), masking viral RNA from host cell sensory
proteins (Cardenas et al., 2006; Mibayashi et al., 2007), to specific inhibition of host cell
dsRNA sensors or signaling molecules that link these sensor molecules to transcription factors
that regulate type I interferon transcription (Andrejeva et al., 2004; Basler et al., 2003; Li et
al., 2005; Loo et al., 2006). Studies with Sindbis virus suggest that host cell shutoff plays a
major role in regulating viral type I interferon induction (Gorchakov, Frolova, and Frolov,
2005), though studies with Semliki Forest virus (SFV) also indicate that alphaviruses can
modulate type I IFN responses independently of host shutoff (Breakwell et al., 2007). In this
report, we present evidence that an attenuating mutation at nsP1 position 538 (T538I) in the
neurovirulent strain of Sindbis virus, AR86, modulates type I interferon induction without
affecting this virus’s ability to shut off host cell macromolecular synthesis. Additionally, this
determinant has been shown to play a key role in regulating viral neurovirulence (Heise,
Simpson, and Johnston, 2000), and it is likely that the enhanced type I IFN induction by the
nsP1 538 mutant virus in vivo (figure 1A) is at least partially responsible for its attenuating
effect on AR86. Furthermore, the importance of this determinant in regulating type I IFN
induction by alphaviruses is underscored by our finding that an analogous mutation in another
alphavirus, Ross River Virus, exerts a similar effect on type I IFN induction (figure 4 and 5).
Using a genetically related Sindbis virus, Gorchakov et al. demonstrated that viruses with
mutations resulting in defects in host translation or transcription shutoff induced more type I
interferon (Gorchakov, Frolova, and Frolov, 2005). However, we found either no difference
or a very mild defect in host shutoff with the mutant Sindbis and RRV viruses, as well as
differences in the kinetics of virus induced IRF-3 activation, which is independent of host
shutoff. This finding strongly suggests that these viruses can affect type I IFN induction
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independently of effects on host shutoff. It is also important to note that previous work with
an SFV nsP mutant, which also demonstrated a role for the nonstructural proteins in modulating
type I IFN induction independently of host shutoff effects, did not observe a differential effect
on IRF-3 activation (Breakwell et al., 2007), which raises the possibility that the determinants
in our AR86 and RRV mutants may affect interferon induction through different mechanisms
than those observed with SFV. Furthermore, previous work from our lab and others have
demonstrated a role for VEE to inhibit STAT-1 activation (Simmons et al., 2009; Yin et al.,
2009), a necessary step in the IFN signaling pathway to amplify the type I IFN response
indicating that these viruses may employ additional mechanisms to antagonize this pathway.
However, our analysis in IFN αβ Receptor deficient MEFS, coupled with preliminary data that
wild type RRV does not inhibit STAT-1 activation, further suggests that our determinant is
affecting the initial IFN induction step.
The nsP1 virulence determinant described here might affect type I IFN induction through
several different mechanisms. First, the nsP1 mutant may induce more type I IFN by producing
earlier and/or increased quantities of a viral ligand, for efficient recognition by the host sensors.
Previous studies examining very early times post-infection demonstrated that the AR86 mutant
virus initiated 26S RNA synthesis more quickly than the wild type virus, though both viruses
exhibited equivalent levels of 26S RNA synthesis by 4–6 hours post-infection (Heise et al.,
2003). Although, we did not observe this kinetic difference in our L929 RNA labeling assays,
this likely reflects the time-points analyzed in the current studies. Our earlier results raise the
possibility that early or more abundant 26S RNA synthesis by the mutant virus might be linked
to the difference in type I IFN induction. Preliminary analysis indicates that the RRV mutant
may also produce more viral RNA than the wild type virus (data not shown). In this model,
the wild type virus could delay 26S promoter induction until later times when virus-induced
host shutoff efficiently antagonizes type I interferon induction. The attenuating mutation at
nsP1, however, up-regulates 26S RNA synthesis prior to the time of effective virus-induced
shutoff (Heise et al., 2003). This model suggests that the subgenomic RNA may be a potential
target for host cell sensors, however; this does not rule out a role for multiple viral RNA species,
such as the full length positive or negative sense RNA, or dsRNA complexes to activate IFN
induction. Further investigations will be required to address the exact viral ligand required as
well as the pathway that is mediating this response and whether this mechanism holds true for
both viruses. Second, the nsP1 mutant may induce more type I IFN by altering the structure of
one or more viral RNAs and thereby producing a stronger ligand. Gitlin et al. has reported that
RIG-I plays an important role in responding to Sindbis virus infection (Gitlin et al., 2006),
while PKR has also been shown to contribute to type I IFN induction during flavivirus infection
(Gilfoy and Mason, 2007). Both RIG-I and PKR interact with 5-′triphosphates on uncapped
RNAs (Hornung et al., 2006; Nallagatla et al., 2007; Pichlmair et al., 2006), though both
proteins can also recognize other RNA ligands (Nallagatla and Bevilacqua, 2008; Saito and
Gale, 2008). Both nsP1 and nsP2 proteins are involved in capping viral RNAs and though the
C-terminus of nsP1 has not been implicated in capping activity, it is possible that the
determinant at nsP1 is altering the efficiency of capping viral genomic or subgenomic RNAs
(Ahola and Kaariainen, 1995; Ahola et al., 1997; Hornung et al., 2006; Mi et al., 1989;
Rikkonen, Peranen, and Kaariainen, 1994; Vasiljeva et al., 2000). In this model, the nsP1
mutants are providing the host sensor, RIG-I, with viral ligands that contain free 5′-
triphosphates that lead to stronger IFN-β induction. Finally, though there is no direct evidence
to suggest that the wild type and T538I mutant Sindbis AR86 viruses or RRV and the A532V
RRV mutant differ in their ability to actively suppress type I IFN induction, it is possible that
the mutation is modulating type I IFN induction through different mechanisms in the context
of each virus. Regardless of the ultimate mechanism responsible for the differential type I IFN
induction phenotype, these results further support the idea that determinants in the viral
nonstructural region of alphaviruses play a major role in regulating type I IFN induction, with
a concomitant impact on viral virulence.
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In summary, we have demonstrated that wild type AR86 virus was a poor inducer of type I
interferon, while the mutant T538I virus containing an attenuating Ile codon at nsP1 position
538 induced a robust type I interferon response in vitro and in vivo. An analogous determinant
exhibited a similar effect in another, distantly related alphavirus (RRV), suggesting that this
determinant plays an important role in regulating type I IFN induction by multiple alphaviruses.
The altered interferon induction was independent of virus-induced host translation or
transcription shutoff, suggesting that the determinant within the nsP1/nsP2 cleavage site acts
through a more specific mechanism to modulate the host type I interferon response.
Materials and Methods
Viruses and Cell Culture
The AR86 molecular clones pS300 (wild type nsP1 538 Thr) and pS340 (mutant nsP1 538 Ile)
were described previously (Heise, Simpson, and Johnston, 2000). The wild type Ross River
Virus molecular clone, pRR64 (Kuhn et al., 1991), was generously provided by Dr. Richard
Kuhn (Purdue University). The Ross River Virus mutant, pRR64-A532V, was generated by
introducing a single nucleotide change (thymine to guanine) at nucleotide position 1670, by
PCR mutagenesis resulting in a single codon change from an Alanine (wild type) to Valine
(A532V) at nsP1 position 532.
Viral stocks were generated by in vitro transcription as previously described (Heise et al.,
2003; Morrison et al., 2006). Briefly, cDNA plasmids were linearized and used as templates
for full length RNA transcripts generated by SP6-specific mMessage mMachine in vitro
transcription kits (Ambion). Transcripts were electroporated into BHK-21 cells using a Bio-
Rad electroporator. Supernatants were harvested 24 hours later, centrifuged for 20 min at 3,000
RPM, and frozen in 0.5 ml aliquots. Alternatively, electroporated supernatants were pelleted
through a 20% (w/v) sucrose/phosphate buffered saline (PBS) cushion at 72,000 × g by
ultracentrifugation (four hours) to concentrate viral stocks. The pelleted viruses were
resuspended in PBS and 0.1ml aliquots were frozen at −80°C. Viral titers were determined by
standard plaque assays on BHK-21 cells.
BHK-21 cells were maintained in alpha minimum essential medium (Gibco) supplemented
with 10% bovine calf serum (BioWhittaker), 10% tryptose phosphate broth, and 0.29 mg/ml
of L-glutamine. L929 mouse fibroblast cells were maintained in alpha minimum essential
medium (Gibco) supplemented with 10% bovine calf serum, 10% tryptose phosphate broth,
and 0.29 mg/ml of L-glutamine. Neuro2A mouse neuroblastoma cells (N2A) were grown in
MEM containing nonessential amino acids and 10% fetal bovine serum (HyClone). HEC-1B
cells (ATCC) were grown in MEM containing 10% fetal bovine serum, 0.29 mg of L-glutamine
per ml, and penicillin/streptomycin. Primary Mouse Embryonic Fibroblast (MEFS) cells were
generated from 13–15 day old Sv/129 wild type or IFN αβ receptor deficient (IFNR−/−)
embryos and maintained in DMEM/F12 media containing 10% Fetal Bovine Serum, 10%
tryptose phosphate broth, 0.29 mg/ml of L-glutamine, and 50ug/ml of gentamicin (Gibco).
Animal studies
Specific pathogen-free six-week old female CD-1 mice were obtained from Charles River
Breeding Laboratories (Raleigh, NC), while C57Bl/6J mice were bred in house. Animal
housing and care were in accordance with all University of North Carolina at Chapel Hill
Institutional Animal Care and Use Committee guidelines. In all studies, six- to eight-week-old
mice (groups of 3 to 6 animals/study) were anesthetized with Ketamine supplemented with
Xylazine (Barber Med.) prior to intracranial (i.c.) inoculation with a standard dose of 103 PFU
of virus in diluent [phosphate-buffered saline (PBS, pH 7.4)], supplemented with 1% donor
calf serum (DCS, Gibco)). Mock infected mice received diluent alone. At the indicated
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timepoints, mice were bled from the tail vein and sera were frozen at −80°C until analyzed for
type I interferon by bioassay (see below).
Type I IFN bioassays
Total amounts of type I IFN were measured by using an interferon bioassay as previously
described (Shabman et al., 2007). Briefly, L929 cells were seeded in 96 well plates. Samples,
including the standards, were acidified to a pH ≤ 2.0 for 24 hours, then neutralized to pH of
7.4, UV treated for 10 minutes to inactivate residual virus, and added to cells in a titration of
serial two-fold dilutions. After overnight incubation, 50ul of a 4×106 PFU/ml stock of
encephalomyocarditis virus (EMCV) was added to each well. Twenty-four hours post-
infection, cell viability was determined using 3-(4, 5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT, Sigma) assay, and the absorbance was read on a
microplate reader at 570nm. The IFN in each sample was compared to an IFN standard (from
Chemicon or R&D Systems that has been normalized to the National Institutes of Health
reference IFN) present in each plate and converted to international units (IU/ml).
Quantitative real-time PCR analysis
L929 cells were seeded in 6-well dishes and either mock infected or infected with RRV wild
type and A532V RRV mutant viruses at an MOI of 5. At the indicated time points, total RNA
was isolated using the Trizol (Invitrogen) and the PureLink RNA Mini Kit protocol
(Invitrogen). Total RNA was reverse transcribed using random primers and SuperScript III
Reverse Transcriptase Kit (Invitrogen). cDNAs were then probed for IFN-beta and 18S rRNA
message using TaqMan real-time PCR with primer probe sets (Applied Biosystems) and
analyzed on the Prism 7000 machine (Applied Biosystems).
Analysis of Protein Synthesis
L929, BHK-21, or Neuro2A cells were either mock infected or infected with the Sindbis AR86
or RRV viruses at an MOI of 50 and 10 (BHK and N2A). At various times post-infection, the
media was removed and cells were starved with Minimum Essential Eagle Medium with
Earle’s salts lacking methionine and cysteine (MP biomedicals) for 1 hour at 37°C. The
starvation media was then replaced with media supplemented with 33μCi of 35S-methionine
and 35S-cysteine (Amersham Pro-mix) and incubated at 37°C for one hour. Following each
labeling period, cells were lysed in NP-40 Lysis buffer containing protease inhibitors (Roche).
Equal cell lysates were analyzed on a 10% sodium dodecyl sulphate polyacrylamide gel (SDS-
PAGE). Gels were fixed in buffer containing 10% acetic acid and 40% methanol. The gels
were then dried, exposed to a phosphoimaging screen, and scanned using a Storm
Phosphoimager (GE Healthcare). β-actin bands were quantified using ImageQuant software
(GE Healthcare), and samples are represented as comparison to mock infected cells.
Analysis of Host RNA Synthesis
L929, BHK, or Neuro2A cells were either mock infected or infected with the Sindbis AR86
or the RRV viruses at an MOI of 50 and 10 (BHK and N2A). After 1 hour incubation, 2ml of
media were added back to cells. At various times post-infection (2, 5, 8, and 16hpi), the media
were replaced with media supplemented with 20uCi/ml [3H]-uridine (in the presence or
absence of actinomycin D (1ug/ml)). The cells were labeled for a total of 3 hours, then washed
with 1XPBS and lysed in Trizol (Invitrogen). RNA was extracted and equal volumes were
denatured in glyoxal and dimethyl sulfoxide (DMSO) for 1 hour at 50°C. The RNA was
analyzed on a 0.8% agarose NaPO4 gel. The agarose gel was washed twice in methanol
followed by overnight incubation in 2.5% 2, 5-diphenyloxazole (PPO) in methanol. The gel
was washed three times in water to precipitate the PPO, dried, and exposed to film.
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SDS-PAGE and Western Blot Analysis
Protein extracts were resolved on 10% SDS-PAGE followed by transfer to a PVDF membrane.
Anti-IRF-3 C-20 antibody (Santa Cruz) was used for detection of phosphorylated IRF-3 in
L929 cells. For re-probing of the membranes, anti-β-actin (Sigma) antibodies were used.
Membranes were washed and incubated in the appropriate anti-rabbit and anti-goat secondary
antibodies.
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Figure 1. The mutant SIN T538I virus induces more type I interferon
A) Groups of six-week old (n=3) CD-1 mice were infected with diluent alone, wild type Sindbis
AR86, or Sindbis T538I mutant at 1×103 pfu via the intracranial (i.c.) route. Serum was
harvested at the indicated time points (hours) and diluted (1:10) into media. B) L929 cells were
either mock infected or infected with wild type AR86 or T538I mutant at an MOI of 5.0 and
supernatants were harvested at 18 hours post-infection. Serum and supernatants were subjected
to an interferon bioassay on L929 cells. Each bar represents the average of triplicate samples
and the p values were determined by ANOVA statistical analysis. Error bars represent the
standard error of the mean. The limit of detection in each bioassay was 31IU/ml.
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Figure 2. The Sindbis T538I mutant virus shuts off host RNA transcription and protein translation
with similar kinetics to the wild type AR86
L929 cells were mock infected (M) or infected with wild type Sindbis AR86 (T) or mutant
T538I (I) at an MOI of 50. A) To analyze host RNA synthesis, at various times post-infection
(2, 5, 8, and 16 hours), the media was replaced with media containing 20μCi/ml of 3H-Uridine
and cells were labeled for a total of 3 hours. Total RNA was harvested and analyzed by agarose
gel electrophoresis as previously described. B) To analyze host protein synthesis, L929 cells
were labeled with 35S Met/Cys for 1 hour at the hours indicated and cell lysates (in duplicates)
were analyzed by SDS-PAGE. C) Residual host cell protein synthesis in figure 2B was
evaluated by measuring the amount of radioactivity detected in the protein band corresponding
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to actin (as marked by the arrow) and normalized to the amount of radioactivity detected in the
same protein band in mock infected cells (AR86-□, T538I-▲). The data shown are
representative of two independent experiments.
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Figure 3. Characterizations of the RRV A532V mutant virus
A) Schematic diagram of the single amino acid substitutions in the Sindbis AR86 (T538I) and
Ross River Virus (A532I and A532V) mutants. B) Single step growth curve. BHK cells were
infected at an MOI of 5 with either RRV (■) or A532V (△) viruses. Supernatants at 1, 4, 7,
10, 13, and 25hpi were analyzed by plaque assay. C) Multi-step growth curve. BHK-21 cells
were infected at an MOI of 0.01 with either RRV (■) or A532V (△) viruses. Supernatants at
4, 7, 10, 13, 16, and 25hpi were analyzed by plaque assays. Each data point represent the
average of triplicate samples and significance was determined by a 2-factor ANOVA statistical
analysis (*p<0.05, **p<0.01). Error bars represent the standard error of the mean.
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Figure 4. The RRV A532V mutant virus induces more type I IFN than the wild type
L929 cells were infected with RRV and A532V viruses at an MOI of 5. A) Type I IFN bioassays
were performed on the supernatants harvested at 24 hpi. The limit of detection for the bioassay
is 7 IU/ml. B) and C) Total RNA was extracted at 6 hpi (B) or 12 hpi (C) and analyzed by
quantitative real time PCR (Applied Biosystems) for IFN-beta message transcripts. The data
are represented as the fold induction over Mock infected cells and have been normalized to
18S rRNA. Each bar above represents the average of triplicate samples and the p values were
determined by ANOVA statistical analysis. Error bars represent the standard error of the mean.
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Figure 5. The RRV mutant virus induces more IFN than the wildtype RRV in the absence of the
Type I IFN αβ Receptor
A) Sv/129 MEFS and B) Sv/129 IFNR−/− MEFS were infected with RRV and A532V viruses
at an MOI of 5. Type I IFN bioassays were performed on the supernatants harvested at 24 hpi.
Each bar represents the average of triplicate samples and the p values were determined by
ANOVA statistical analysis. Error bars represent the standard error of the mean and the limit
of detection for each bioassay is 61 IU/ml).
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Figure 6. Characterization of virus-induced shutoff by the RRV A532V mutant
L929 cells were either mock infected (M) or infected at an MOI of 50 with RRV (R) or A532V
(V). A) At various times post-infection (2, 5, 8, and 16 hrs), cells were labeled with 20μCi/ml
of 3H-Uridine (as previously described) for analysis of host RNA synthesis. B) L929 cells
were labeled with 35S Met/Cys at the indicated times post-infection for 1 hour to monitor host
protein synthesis. Total cell lysates (duplicates) were analyzed by SDS-PAGE as described in
the materials and methods. C) The kinetics of cellular β-actin protein synthesis was evaluated
by measuring the amount of radioactivity detected by densitometry in the β-actin protein band
in the infected cells and normalized to the mock infected cells at 24hpi. D) L929 cells were
either mock infected or infected with RRV or A532V mutant viruses at an MOI (50).
Supernatants at 24hpi were analyzed for IFN by bioassay as previously described. The limit
of detection in this assay is 2 IU/ml and each bar represents the average of triplicate samples.
The p-values were determined by ANOVA statistical analysis and error bars represent the
standard error of the mean
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Figure 7. The RRV A532V mutant robustly induces IRF-3 phosphorylation compared to wild type
virus
A) L929 cells were either mock infected, infected with RRV and A532V viruses at an MOI of
5, or transfected with 1ug of poly I:C with Lipofectamine 2000 (Invitrogen). Cells were lysed
at the indicated hours in NP40 lysis buffers containing protease and phosphatase inhibitors.
20ug of total protein was analyzed by SDS-PAGE and probed with an anti-IRF-3 antibody
(Santa Cruz, C-20) for phosphorylated murine IRF-3 (p-IRF-3). The membranes were then re-
probed with an anti-β-actin antibody (Sigma). B) The phosphorylated IRF-3 bands in (A) were
quantified using ImageQuant 5.0 and represented as fold over mock. The data shown are
representative of three independent experiments.
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